The research team projects that the Biologics & Biosimilars market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
fizer
Novartis
AbbVie
Roche
Novo Nordisk
Amgen
Lilly
Johnson & Johnson
Sanofi
Merck
Gelgen Biopharma
Hospira
3sbio
Sandoz
Biotech Pharma
Changchun High Tech
Mylan
Teva
CP Guojian Pharmacy
By Type
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
By Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biologics & Biosimilars 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biologics & Biosimilars Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biologics & Biosimilars Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics & Biosimilars market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Biologics & Biosimilars Revenue
1.5 Market Analysis by Type
1.5.1 Global Biologics & Biosimilars Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Antibiotic
1.5.3 Enzyme
1.5.4 Hormone
1.5.5 Non-Patented Biological Reagents
1.5.6 Other
1.6 Market by Application
1.6.1 Global Biologics & Biosimilars Market Share by Application: 2021-2026
1.6.2 Tumor
1.6.3 Diabetes
1.6.4 Cardiovascular
1.6.5 Hemophilia
1.6.6 Other
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Biologics & Biosimilars Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Biologics & Biosimilars Market Players Profiles
3.1 fizer
3.1.1 fizer Company Profile
3.1.2 fizer Biologics & Biosimilars Product Specification
3.1.3 fizer Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Novartis
3.2.1 Novartis Company Profile
3.2.2 Novartis Biologics & Biosimilars Product Specification
3.2.3 Novartis Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 AbbVie
3.3.1 AbbVie Company Profile
3.3.2 AbbVie Biologics & Biosimilars Product Specification
3.3.3 AbbVie Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Roche
3.4.1 Roche Company Profile
3.4.2 Roche Biologics & Biosimilars Product Specification
3.4.3 Roche Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Novo Nordisk
3.5.1 Novo Nordisk Company Profile
3.5.2 Novo Nordisk Biologics & Biosimilars Product Specification
3.5.3 Novo Nordisk Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 Amgen
3.6.1 Amgen Company Profile
3.6.2 Amgen Biologics & Biosimilars Product Specification
3.6.3 Amgen Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Lilly
3.7.1 Lilly Company Profile
3.7.2 Lilly Biologics & Biosimilars Product Specification
3.7.3 Lilly Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Johnson & Johnson
3.8.1 Johnson & Johnson Company Profile
3.8.2 Johnson & Johnson Biologics & Biosimilars Product Specification
3.8.3 Johnson & Johnson Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Sanofi
3.9.1 Sanofi Company Profile
3.9.2 Sanofi Biologics & Biosimilars Product Specification
3.9.3 Sanofi Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Merck
3.10.1 Merck Company Profile
3.10.2 Merck Biologics & Biosimilars Product Specification
3.10.3 Merck Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 Gelgen Biopharma
3.11.1 Gelgen Biopharma Company Profile
3.11.2 Gelgen Biopharma Biologics & Biosimilars Product Specification
3.11.3 Gelgen Biopharma Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Hospira
3.12.1 Hospira Company Profile
3.12.2 Hospira Biologics & Biosimilars Product Specification
3.12.3 Hospira Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.13 3sbio
3.13.1 3sbio Company Profile
3.13.2 3sbio Biologics & Biosimilars Product Specification
3.13.3 3sbio Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.14 Sandoz
3.14.1 Sandoz Company Profile
3.14.2 Sandoz Biologics & Biosimilars Product Specification
3.14.3 Sandoz Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.15 Biotech Pharma
3.15.1 Biotech Pharma Company Profile
3.15.2 Biotech Pharma Biologics & Biosimilars Product Specification
3.15.3 Biotech Pharma Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.16 Changchun High Tech
3.16.1 Changchun High Tech Company Profile
3.16.2 Changchun High Tech Biologics & Biosimilars Product Specification
3.16.3 Changchun High Tech Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.17 Mylan
3.17.1 Mylan Company Profile
3.17.2 Mylan Biologics & Biosimilars Product Specification
3.17.3 Mylan Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.18 Teva
3.18.1 Teva Company Profile
3.18.2 Teva Biologics & Biosimilars Product Specification
3.18.3 Teva Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.19 CP Guojian Pharmacy
3.19.1 CP Guojian Pharmacy Company Profile
3.19.2 CP Guojian Pharmacy Biologics & Biosimilars Product Specification
3.19.3 CP Guojian Pharmacy Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Biologics & Biosimilars Market Competition by Market Players
4.1 Global Biologics & Biosimilars Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Biologics & Biosimilars Revenue Market Share by Market Players (2015-2020)
4.3 Global Biologics & Biosimilars Average Price by Market Players (2015-2020)
5 Global Biologics & Biosimilars Production by Regions (2015-2020)
5.1 North America
5.1.1 North America Biologics & Biosimilars Market Size (2015-2020)
5.1.2 Biologics & Biosimilars Key Players in North America (2015-2020)
5.1.3 North America Biologics & Biosimilars Market Size by Type (2015-2020)
5.1.4 North America Biologics & Biosimilars Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Biologics & Biosimilars Market Size (2015-2020)
5.2.2 Biologics & Biosimilars Key Players in East Asia (2015-2020)
5.2.3 East Asia Biologics & Biosimilars Market Size by Type (2015-2020)
5.2.4 East Asia Biologics & Biosimilars Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Biologics & Biosimilars Market Size (2015-2020)
5.3.2 Biologics & Biosimilars Key Players in Europe (2015-2020)
5.3.3 Europe Biologics & Biosimilars Market Size by Type (2015-2020)
5.3.4 Europe Biologics & Biosimilars Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Biologics & Biosimilars Market Size (2015-2020)
5.4.2 Biologics & Biosimilars Key Players in South Asia (2015-2020)
5.4.3 South Asia Biologics & Biosimilars Market Size by Type (2015-2020)
5.4.4 South Asia Biologics & Biosimilars Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Biologics & Biosimilars Market Size (2015-2020)
5.5.2 Biologics & Biosimilars Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Biologics & Biosimilars Market Size by Type (2015-2020)
5.5.4 Southeast Asia Biologics & Biosimilars Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Biologics & Biosimilars Market Size (2015-2020)
5.6.2 Biologics & Biosimilars Key Players in Middle East (2015-2020)
5.6.3 Middle East Biologics & Biosimilars Market Size by Type (2015-2020)
5.6.4 Middle East Biologics & Biosimilars Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Biologics & Biosimilars Market Size (2015-2020)
5.7.2 Biologics & Biosimilars Key Players in Africa (2015-2020)
5.7.3 Africa Biologics & Biosimilars Market Size by Type (2015-2020)
5.7.4 Africa Biologics & Biosimilars Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Biologics & Biosimilars Market Size (2015-2020)
5.8.2 Biologics & Biosimilars Key Players in Oceania (2015-2020)
5.8.3 Oceania Biologics & Biosimilars Market Size by Type (2015-2020)
5.8.4 Oceania Biologics & Biosimilars Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Biologics & Biosimilars Market Size (2015-2020)
5.9.2 Biologics & Biosimilars Key Players in South America (2015-2020)
5.9.3 South America Biologics & Biosimilars Market Size by Type (2015-2020)
5.9.4 South America Biologics & Biosimilars Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Biologics & Biosimilars Market Size (2015-2020)
5.10.2 Biologics & Biosimilars Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Biologics & Biosimilars Market Size by Type (2015-2020)
5.10.4 Rest of the World Biologics & Biosimilars Market Size by Application (2015-2020)
6 Global Biologics & Biosimilars Consumption by Region (2015-2020)
6.1 North America
6.1.1 North America Biologics & Biosimilars Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Biologics & Biosimilars Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Biologics & Biosimilars Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Biologics & Biosimilars Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Biologics & Biosimilars Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Biologics & Biosimilars Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Biologics & Biosimilars Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Biologics & Biosimilars Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Biologics & Biosimilars Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Biologics & Biosimilars Consumption by Countries
7 Global Biologics & Biosimilars Production Forecast by Regions (2021-2026)
7.1 Global Forecasted Production of Biologics & Biosimilars (2021-2026)
7.2 Global Forecasted Revenue of Biologics & Biosimilars (2021-2026)
7.3 Global Forecasted Price of Biologics & Biosimilars (2021-2026)
7.4 Global Forecasted Production of Biologics & Biosimilars by Region (2021-2026)
7.4.1 North America Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.3 Europe Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.7 Africa Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.9 South America Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Biologics & Biosimilars by Application (2021-2026)
8 Global Biologics & Biosimilars Consumption Forecast by Regions (2021-2026)
8.1 North America Forecasted Consumption of Biologics & Biosimilars by Country
8.2 East Asia Market Forecasted Consumption of Biologics & Biosimilars by Country
8.3 Europe Market Forecasted Consumption of Biologics & Biosimilars by Countriy
8.4 South Asia Forecasted Consumption of Biologics & Biosimilars by Country
8.5 Southeast Asia Forecasted Consumption of Biologics & Biosimilars by Country
8.6 Middle East Forecasted Consumption of Biologics & Biosimilars by Country
8.7 Africa Forecasted Consumption of Biologics & Biosimilars by Country
8.8 Oceania Forecasted Consumption of Biologics & Biosimilars by Country
8.9 South America Forecasted Consumption of Biologics & Biosimilars by Country
8.10 Rest of the world Forecasted Consumption of Biologics & Biosimilars by Country
9 Global Biologics & Biosimilars Sales by Type (2015-2026)
9.1 Global Biologics & Biosimilars Historic Market Size by Type (2015-2020)
9.2 Global Biologics & Biosimilars Forecasted Market Size by Type (2021-2026)
10 Global Biologics & Biosimilars Consumption by Application (2015-2026)
10.1 Global Biologics & Biosimilars Historic Market Size by Application (2015-2020)
10.2 Global Biologics & Biosimilars Forecasted Market Size by Application (2021-2026)
11 Global Biologics & Biosimilars Manufacturing Cost Analysis
11.1 Biologics & Biosimilars Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Biologics & Biosimilars
12 Global Biologics & Biosimilars Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Biologics & Biosimilars Distributors List
12.3 Biologics & Biosimilars Customers
12.4 Biologics & Biosimilars Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer